These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23424907)

  • 1. [Sounding board. First trimester Down syndrome screening in France].
    Simon-Bouy B; Royère D; Levy P
    Rev Prat; 2012 Dec; 62(10):1340-4. PubMed ID: 23424907
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal screening for birth defects: an update.
    Morris K
    Mo Med; 2004; 101(2):121-4. PubMed ID: 15119110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current controversies in prenatal diagnosis 2: Down syndrome screening: is ultrasound better than cell-free nucleic acids in maternal blood?
    van Lith JM; Benacerraf BR; Yagel S
    Prenat Diagn; 2011 Mar; 31(3):231-4. PubMed ID: 21374636
    [No Abstract]   [Full Text] [Related]  

  • 4. Combining first and second trimester markers for Down syndrome screening: think twice.
    Cocciolone R; Brameld K; O'Leary P; Haan E; Muller P; Shand K
    Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):492-500. PubMed ID: 19032666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which contingent sequential screening protocol?
    Larsen SO; Christiansen M; Norgaard-Pedersen B
    Prenat Diagn; 2005 Dec; 25(12):1168-9; author reply 1169-70. PubMed ID: 16317663
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.
    Wyatt P
    Prenat Diagn; 2007 Feb; 27(2):186-7. PubMed ID: 17266162
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential testing for Down syndrome: the impact on estimated risk.
    Chasen ST; Wasden S
    Prenat Diagn; 2012 Feb; 32(2):138-41. PubMed ID: 22418957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From a genetic innovation to mass health programmes: the diffusion of Down's Syndrome prenatal screening and diagnostic techniques in France.
    Vassy C
    Soc Sci Med; 2006 Oct; 63(8):2041-51. PubMed ID: 16797810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening for Down syndrome.
    Ogle RF; Chitty LS
    Hosp Med; 1998 Aug; 59(8):632-6. PubMed ID: 9829057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in antenatal screening for Down syndrome.
    Wald NJ; Hackshaw AK
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Aug; 14(4):563-80. PubMed ID: 10985931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Down syndrome screening: from medical criticism to crisis of conscience].
    Leblanc P; Arduin PO
    J Gynecol Obstet Biol Reprod (Paris); 2010 Oct; 39(6):509-13. PubMed ID: 20692772
    [No Abstract]   [Full Text] [Related]  

  • 14. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach].
    Senat MV; Rozenberg P; Bernard JP; Ville Y
    J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1):11-27. PubMed ID: 11240502
    [No Abstract]   [Full Text] [Related]  

  • 15. Unconjugated estriol values between 14 and 22 weeks of gestation in relation to prenatal screening for Down syndrome.
    Bestwick JP; Huttly WJ; Wald NJ
    Prenat Diagn; 2012 Mar; 32(3):299-301. PubMed ID: 22430732
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
    Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
    Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trisomy 21, after a half century].
    Nau JY
    Rev Med Suisse; 2009 Feb; 5(190):380. PubMed ID: 19264068
    [No Abstract]   [Full Text] [Related]  

  • 18. Second trimester prenatal ultrasound and screening for Down syndrome.
    Benn PA; Egan JF
    Prenat Diagn; 2007 Sep; 27(9):884. PubMed ID: 17724762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of second-trimester serum screening in the post-first-trimester screening era.
    Shamshirsaz AA; Benn P; Egan JF
    Clin Lab Med; 2010 Sep; 30(3):667-76. PubMed ID: 20638580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.